Prevalence and factors associated with long COVID in adults from Southern Brazil: findings from the PAMPA cohort

Detalhes bibliográficos
Autor(a) principal: Feter, Natan
Data de Publicação: 2023
Outros Autores: Lucia Caputo, Eduardo, Santos Leite, Jayne, Mendes Delpino, Felipe, Silveira da Silva, Luísa, Pereira Vieira, Yohana, de Almeida Paz, Isabel, Quadros Santos Rocha, Juliana, Nascimento da Silva, Carine, Schröeder, Natália, Cozzensa da Silva, Marcelo, José Rombaldi, Airton
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Cadernos de Saúde Pública
Texto Completo: https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/8450
Resumo: Most COVID-19 survivors have reported experiencing persistent symptoms after the infection – these types of cases are known as long COVID. Since Brazil was an epicenter of the COVID-19 pandemic, a high burden of long COVID is expected. This study aimed to identify the prevalence and factors associated with long COVID in adults in Southern Brazil, analyzing data from the PAMPA cohort. Participants filled out a self-reported online questionnaire in June 2022. This study only included subjects who tested positive for COVID-19. Long COVID was defined by any symptoms that persisted for at least three months after the SARS-CoV-2 infection. Poisson’s regression models with robust variance were used to identify factors associated with long COVID; and results were reported as prevalence ratios (PR) and respective 95% confidence intervals (95%CI). A total of 1,001 participants (77.4% women, mean age [SD] = 38.3 [11.9] years) were analyzed. The prevalence of long COVID among these patients was 77.4% (95%CI: 74.7; 79.9). The likelihood of long COVID was higher in unvaccinated participants (PR = 1.23, 95%CI: 1.06; 1.42), in those with chronic conditions (PR = 1.13, 95%CI: 1.04; 1.24), and in those who were hospitalized due to the COVID-19 infection (PR = 1.24, 95%CI: 1.16; 1.32). This prevalence was also higher in women (PR = 1.21, 95%CI: 1.09; 1.33) than in men. Physical activity was associated with a reduced likelihood of fatigue, neurological complications, coughing, and headaches as persistent symptoms after a COVID-19 infection. It was found that three out of four adults in Southern Brazil experienced long COVID. Public policies aiming to reduce the burden of long COVID must be prioritized, especially in groups that are at higher risk of developing this harmful condition.
id FIOCRUZ-5_46bdc42342f3663a67e6a2d34a869fd9
oai_identifier_str oai:ojs.teste-cadernos.ensp.fiocruz.br:article/8450
network_acronym_str FIOCRUZ-5
network_name_str Cadernos de Saúde Pública
repository_id_str
spelling Prevalence and factors associated with long COVID in adults from Southern Brazil: findings from the PAMPA cohortPrevalencia y factores asociados con el COVID largo en adultos del Sur de Brasil: hallazgos de la cohorte PAMPAPrevalência e fatores associados à COVID longa em adultos do Sul do Brasil: achados da coorte PAMPA COVID Longa; Vacinação; Estudos de CoortesCOVID Largo; Vacunación; Estudios de CohortesLong COVID; Vaccination; Cohort StudiesMost COVID-19 survivors have reported experiencing persistent symptoms after the infection – these types of cases are known as long COVID. Since Brazil was an epicenter of the COVID-19 pandemic, a high burden of long COVID is expected. This study aimed to identify the prevalence and factors associated with long COVID in adults in Southern Brazil, analyzing data from the PAMPA cohort. Participants filled out a self-reported online questionnaire in June 2022. This study only included subjects who tested positive for COVID-19. Long COVID was defined by any symptoms that persisted for at least three months after the SARS-CoV-2 infection. Poisson’s regression models with robust variance were used to identify factors associated with long COVID; and results were reported as prevalence ratios (PR) and respective 95% confidence intervals (95%CI). A total of 1,001 participants (77.4% women, mean age [SD] = 38.3 [11.9] years) were analyzed. The prevalence of long COVID among these patients was 77.4% (95%CI: 74.7; 79.9). The likelihood of long COVID was higher in unvaccinated participants (PR = 1.23, 95%CI: 1.06; 1.42), in those with chronic conditions (PR = 1.13, 95%CI: 1.04; 1.24), and in those who were hospitalized due to the COVID-19 infection (PR = 1.24, 95%CI: 1.16; 1.32). This prevalence was also higher in women (PR = 1.21, 95%CI: 1.09; 1.33) than in men. Physical activity was associated with a reduced likelihood of fatigue, neurological complications, coughing, and headaches as persistent symptoms after a COVID-19 infection. It was found that three out of four adults in Southern Brazil experienced long COVID. Public policies aiming to reduce the burden of long COVID must be prioritized, especially in groups that are at higher risk of developing this harmful condition.La mayoría de los supervivientes de la COVID-19 relató síntomas persistentes tras la infección, también conocida como COVID largo. Brasil fue un epicentro de la pandemia de COVID-19, así, se espera una alta carga de COVID largo. El objetivo de este estudio fue identificar la prevalencia y los factores asociados con la COVID largo en adultos en el Sur de Brasil. Se analizaron datos de la cohorte PAMPA. Los participantes rellenaron un cuestionario en línea autoadministrado en junio de 2022. Solo se incluyeron los participantes que dieron positivo para COVID-19. La COVID largo fue definida como cualquier síntoma que persistió durante al menos tres meses tras la infección del SARS-CoV-2. Se utilizaron los modelos de regresión de Poisson con varianza robusta para identificar factores asociados con el COVID largo; se relataron los resultados como razón de prevalencia (RP) y sus respectivos intervalos de 95% confianza de 95% (IC95%). En total, se analizaron 1.001 participantes (el 77,4% mujeres, edad media [DP] = 38,3 [11,9] años). La prevalencia del COVID largo fue del 77,4% (IC95%: 74,7; 79,9). La probabilidad del COVID largo fue más alta en participantes no vacunados (RP = 1,23, IC95%: 1,06; 1,42), personas con condiciones crónicas (RP = 1,13, IC95%: 1,04; 1,24) y pacientes hospitalizados debido a la infección por COVID-19 (RP = 1,24, IC95%: 1,16; 1,32) en comparación con sus contrapartes. La prevalencia fue más alta en mujeres (RP = 1,21, IC95%: 1,09; 1,33) que en hombres. La actividad física se asoció con la probabilidad reducida de fatiga, complicaciones neurológicas, tos y dolor de cabeza como síntomas persistentes tras la infección por COVID-19. Tres de cada cuatro adultos en el Sur de Brasil han tenido COVID largo. Se deben priorizar las políticas públicas destinadas a reducir la carga del COVID largo, sobre todo en los grupos de mayor riesgo para esta condición.A maior parte dos sobreviventes da COVID-19 relatou sintomas persistentes após a infecção, também conhecida como COVID longa. O Brasil foi um epicentro da pandemia de COVID-19, logo, espera-se uma alta carga de COVID longa. Este estudo teve como objetivo identificar a prevalência e os fatores associados à COVID longa em adultos no Sul do Brasil. Foram analisados dados da coorte PAMPA. Os participantes preencheram um questionário online autoaplicável em junho de 2022. Foram incluídos apenas os participantes que testaram positivo para COVID-19. A COVID longa foi definida como qualquer sintoma que persistiu por pelo menos três meses após a infecção do SARS-CoV-2. Os modelos de regressão de Poisson com variância robusta foram usados para identificar fatores associados à COVID longa; os resultados foram relatados como razão de prevalência (RP) e seus respectivos intervalos de 95% de confiança (IC95%). Ao todo, 1.001 participantes (77,4% mulheres, idade média [DP] = 38,3 [11,9] anos) foram analisados. A prevalência da COVID longa foi de 77,4% (IC95%: 74,7; 79,9). A probabilidade da COVID longa foi maior em participantes não vacinados (RP = 1,23, IC95%: 1,06; 1,42), pessoas com condições crônicas (RP = 1,13, IC95%: 1,04; 1,24), e pacientes hospitalizados devido à infecção por COVID-19 (RP = 1,24, IC95%: 1,16; 1,32) em comparação com as contrapartes. A prevalência foi maior em mulheres (RP = 1,21, IC95%: 1,09; 1,33) do que em homens. A atividade física foi associada à probabilidade reduzida de fadiga, complicações neurológicas, tosse e dor de cabeça como sintomas persistentes após a infecção por COVID-19. Três em cada quatro adultos no Sul do Brasil tiveram COVID longa. Políticas públicas que visem reduzir a carga da covid longa devem ser priorizadas, especialmente nos grupos de maior risco desta condição.Reports in Public HealthCadernos de Saúde Pública2023-12-05info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/xmlapplication/pdfhttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/8450Reports in Public Health; Vol. 39 No. 12 (2023): DecemberCadernos de Saúde Pública; v. 39 n. 12 (2023): Dezembro1678-44640102-311Xreponame:Cadernos de Saúde Públicainstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZenghttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/8450/18837https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/8450/18838Copyright (c) 2023 Cadernos de Saúde Públicainfo:eu-repo/semantics/openAccessFeter, NatanLucia Caputo, EduardoSantos Leite, JayneMendes Delpino, FelipeSilveira da Silva, LuísaPereira Vieira, Yohanade Almeida Paz, IsabelQuadros Santos Rocha, JulianaNascimento da Silva, CarineSchröeder, NatáliaCozzensa da Silva, MarceloJosé Rombaldi, Airton2023-12-05T16:28:51Zoai:ojs.teste-cadernos.ensp.fiocruz.br:article/8450Revistahttps://cadernos.ensp.fiocruz.br/ojs/index.php/csphttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/oaicadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br1678-44640102-311Xopendoar:2024-03-06T13:09:37.607597Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ)true
dc.title.none.fl_str_mv Prevalence and factors associated with long COVID in adults from Southern Brazil: findings from the PAMPA cohort
Prevalencia y factores asociados con el COVID largo en adultos del Sur de Brasil: hallazgos de la cohorte PAMPA
Prevalência e fatores associados à COVID longa em adultos do Sul do Brasil: achados da coorte PAMPA
title Prevalence and factors associated with long COVID in adults from Southern Brazil: findings from the PAMPA cohort
spellingShingle Prevalence and factors associated with long COVID in adults from Southern Brazil: findings from the PAMPA cohort
Feter, Natan
COVID Longa; Vacinação; Estudos de Coortes
COVID Largo; Vacunación; Estudios de Cohortes
Long COVID; Vaccination; Cohort Studies
title_short Prevalence and factors associated with long COVID in adults from Southern Brazil: findings from the PAMPA cohort
title_full Prevalence and factors associated with long COVID in adults from Southern Brazil: findings from the PAMPA cohort
title_fullStr Prevalence and factors associated with long COVID in adults from Southern Brazil: findings from the PAMPA cohort
title_full_unstemmed Prevalence and factors associated with long COVID in adults from Southern Brazil: findings from the PAMPA cohort
title_sort Prevalence and factors associated with long COVID in adults from Southern Brazil: findings from the PAMPA cohort
author Feter, Natan
author_facet Feter, Natan
Lucia Caputo, Eduardo
Santos Leite, Jayne
Mendes Delpino, Felipe
Silveira da Silva, Luísa
Pereira Vieira, Yohana
de Almeida Paz, Isabel
Quadros Santos Rocha, Juliana
Nascimento da Silva, Carine
Schröeder, Natália
Cozzensa da Silva, Marcelo
José Rombaldi, Airton
author_role author
author2 Lucia Caputo, Eduardo
Santos Leite, Jayne
Mendes Delpino, Felipe
Silveira da Silva, Luísa
Pereira Vieira, Yohana
de Almeida Paz, Isabel
Quadros Santos Rocha, Juliana
Nascimento da Silva, Carine
Schröeder, Natália
Cozzensa da Silva, Marcelo
José Rombaldi, Airton
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Feter, Natan
Lucia Caputo, Eduardo
Santos Leite, Jayne
Mendes Delpino, Felipe
Silveira da Silva, Luísa
Pereira Vieira, Yohana
de Almeida Paz, Isabel
Quadros Santos Rocha, Juliana
Nascimento da Silva, Carine
Schröeder, Natália
Cozzensa da Silva, Marcelo
José Rombaldi, Airton
dc.subject.por.fl_str_mv COVID Longa; Vacinação; Estudos de Coortes
COVID Largo; Vacunación; Estudios de Cohortes
Long COVID; Vaccination; Cohort Studies
topic COVID Longa; Vacinação; Estudos de Coortes
COVID Largo; Vacunación; Estudios de Cohortes
Long COVID; Vaccination; Cohort Studies
description Most COVID-19 survivors have reported experiencing persistent symptoms after the infection – these types of cases are known as long COVID. Since Brazil was an epicenter of the COVID-19 pandemic, a high burden of long COVID is expected. This study aimed to identify the prevalence and factors associated with long COVID in adults in Southern Brazil, analyzing data from the PAMPA cohort. Participants filled out a self-reported online questionnaire in June 2022. This study only included subjects who tested positive for COVID-19. Long COVID was defined by any symptoms that persisted for at least three months after the SARS-CoV-2 infection. Poisson’s regression models with robust variance were used to identify factors associated with long COVID; and results were reported as prevalence ratios (PR) and respective 95% confidence intervals (95%CI). A total of 1,001 participants (77.4% women, mean age [SD] = 38.3 [11.9] years) were analyzed. The prevalence of long COVID among these patients was 77.4% (95%CI: 74.7; 79.9). The likelihood of long COVID was higher in unvaccinated participants (PR = 1.23, 95%CI: 1.06; 1.42), in those with chronic conditions (PR = 1.13, 95%CI: 1.04; 1.24), and in those who were hospitalized due to the COVID-19 infection (PR = 1.24, 95%CI: 1.16; 1.32). This prevalence was also higher in women (PR = 1.21, 95%CI: 1.09; 1.33) than in men. Physical activity was associated with a reduced likelihood of fatigue, neurological complications, coughing, and headaches as persistent symptoms after a COVID-19 infection. It was found that three out of four adults in Southern Brazil experienced long COVID. Public policies aiming to reduce the burden of long COVID must be prioritized, especially in groups that are at higher risk of developing this harmful condition.
publishDate 2023
dc.date.none.fl_str_mv 2023-12-05
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/8450
url https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/8450
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/8450/18837
https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/8450/18838
dc.rights.driver.fl_str_mv Copyright (c) 2023 Cadernos de Saúde Pública
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2023 Cadernos de Saúde Pública
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/xml
application/pdf
dc.publisher.none.fl_str_mv Reports in Public Health
Cadernos de Saúde Pública
publisher.none.fl_str_mv Reports in Public Health
Cadernos de Saúde Pública
dc.source.none.fl_str_mv Reports in Public Health; Vol. 39 No. 12 (2023): December
Cadernos de Saúde Pública; v. 39 n. 12 (2023): Dezembro
1678-4464
0102-311X
reponame:Cadernos de Saúde Pública
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Cadernos de Saúde Pública
collection Cadernos de Saúde Pública
repository.name.fl_str_mv Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv cadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br
_version_ 1798943399663894528